The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; AstraZeneca; Janssen
Consulting or Advisory Role - Bayer
(OPTIONAL) Uncompensated Relationships - AstraZeneca
A phase III trial of capivasertib and abiraterone versus placebo and abiraterone in patients with de novo metastatic hormone-sensitive prostate cancer characterized by PTEN deficiency (CAPItello-281).
 
Karim Fizazi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma; AstraZeneca (Inst); Bayer; Curevac; ESSA (Inst); Janssen Oncology (Inst); Orion; Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; MSD
 
Daniel J. George
Leadership - Capio BioSciences
Honoraria - Acceleron Pharma; American Association for Cancer Research; Axess Oncology; Bayer; EMD Serono; Exelixis; Janssen Oncology; Millennium Medical Publishing; OncLive; Pfizer; Sanofi; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Pfizer; Sanofi; Vizuri
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi; UroToday
 
Maria De Santis
Honoraria - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Ferring; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Ferring; GlaxoSmithKline; Ipsen; Janssen; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Synthon; Takeda
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Roche; Sanofi
 
Noel Clarke
No Relationships to Disclose
 
Andre P. Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Hirotsugu Uemura
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Janssen; Ono Pharmaceutical; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
 
Lynda Grinsted
Employment - AstraZeneca; GlaxoSmithKline (I)
Stock and Other Ownership Interests - AstraZeneca
 
Claire Rooney
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Remy B Verheijen
Employment - AstraZeneca; Johnson & Johnson
Stock and Other Ownership Interests - Aduro Biotech; AstraZeneca; Johnson & Johnson
 
Rana Anjum
Stock and Other Ownership Interests - AstraZeneca
 
Andrew Foxley
Employment - AstraZeneca
Leadership - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Athenex
Travel, Accommodations, Expenses - AstraZeneca
 
Thomas Morris
Employment - AstraZeneca
Travel, Accommodations, Expenses - Evgen; Incanthera; Medivir; Nanobiotix; OncoTherics; Oxford Vacmedix; Wilson Therapeutics